Galaxy Head of Research: The URGENCY of the CLARITY Act is closely related to the battle for control of the Senate
According to ChainCatcher, Galaxy Head of Research Alex Thorn posted on X stating that passing the CLARITY Act currently has greater urgency, one reason being the exceptionally fierce competition for control of the US Senate. If the Democratic Party regains control of the Senate, former Senator Sherrod Brown may resume the position as Chairman of the Senate Banking Committee; however, if he fails to win the Ohio Senate election but Democrats still control the Senate, the committee could be led by Elizabeth Warren.
These potential personnel changes could have a significant impact on the direction of crypto industry regulation, thereby increasing the practical urgency for advancing the CLARITY Act. Note: Elizabeth Warren is not friendly toward the crypto industry; she has previously urged the US Treasury to implement strict supporting regulations for the GENIUS Act and clearly issued guidance prohibiting the use of the Exchange Stabilization Fund or Federal Reserve emergency lending tools and other federal resources to back stablecoins or the crypto industry.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
Crypto prices
More
